Company page
Alzinova Ab
Alzinova Ab is a public company listed on the Swedish market under the ticker ALZ, with a market capitalization of approximately 7.73 million USD. The company focuses on developing innovative treatments for Alzheimer's disease. Alzinova aims to address significant unmet medical needs in the field of neurodegenerative disorders.
- Ticker
- ALZ:OMXSTO
- Asset type
- Stock
- Market cap
- $7.7M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- OMXSTO
- Currency
- SEK